Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6195)
  2. Meeting Abstract (6166)
  3. Review (401)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (160)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11094)
  2. Hematologic Malignancies, Division of (10645)
  3. GSK Faculty (5449)
  4. Adult Leukemia (3723)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (946)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (317)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (268)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1669)
  3. Nature Publishing Group (1118)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13553)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Anti-CCR4 monoclonal antibody KW-0761 (mogamulizumab) or investigator's choice of chemotherapy in subjects with relapsed or refractory adult T-cell leukemia-lymphoma (ATL)
    Meeting Abstract

    Phillips, A. A.; Fields, P.; Hermine, O.; Taylor, G.; DelloukIna, M. L.; Horwitz, S. M.; Ramos, J. C.; Menlane, J. C.; Barta, S. K.; Or, K. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase I trial of autologous CD19-targeted CAR-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated CLL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bartido, S.; Sadelain, M.; Brentjens, R. J.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Differences in disease characteristics, treatment patterns, and outcomes between men (M) and women (W) with follicular lymphoma (FL): Prospective evaluation of 2,650 US patients (pts)
    Meeting Abstract

    Nabhan, C.; Byrtek, M.; Dawson, K. L.; Zhou, X. L.; Ziemiecki, R.; Zelenetz, A. D.; Friedberg, J. W.; Cerhan, J. R.; Flowers, C.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Breast cancer following spinal radiotherapy for a childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS)
    Meeting Abstract

    Moskowitz, C. S.; Malhotra, J.; Chou, J. F.; Wolden, S. L.; Stovall, M.; Armstrong, G. T.; Leisenring, W. M.; Neglia, J. P.; Robison, L. L.; Oeffinger, K. C.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase lb dose escalation trial of SAR650984 (Anti-CD-38 mAb) in combination with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma
    Meeting Abstract

    Martin, T. G.; Hsu, K.; Charpentier, E.; Vij, R.; Baz, R. C.; Benson, D. M.; Lendvai, N.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Treatment-free remission (TER) following nilotinib (NIL) in patients (pis) with chronic myeloid leukemia in chronic phase (CML-CP): ENESTfreedom, ENESTop, ENESTgoal, and ENESTpath
    Meeting Abstract

    Mahon, F. X.; Baccarani, M.; Mauro, M. J.; Hughes, T. P.; Sagilo, G.; Savona, M.; Szczudlo, T. K.; Menssen, H. D.; Keir, C. H.; Walasok, C.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Phase I results
    Meeting Abstract

    Lunning, M. A.; Ruan, J.; Nair, S.; Boruchov, A. M.; Byrne, R.; Gerecitano, J. F.; Hamlin, P. A.; Inserra, B.; Leonard, J.; Lynch, P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Multiple copies of MLL as a commonly detected cytogenetic abnormality in newly diagnosed symptomatic multiple myeloma
    Meeting Abstract

    Landry, C. A.; Londono, D.; Devlin, S.; Jhanwar, S.; Giralt, S.; Landau, H. J.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • CNS involvement in patients with AIDS-related lymphomas
    Meeting Abstract

    Joshi, J.; Mounier, N.; Xue, X. N.; Wang, D.; Ribera, J. M.; Wyen, C.; Dunleavy, K.; Little, R. F.; Wilson, W. H.; Noy, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Vincristine, dactinomycin, cyclophosphamide (VAC) versus VAC/V plus irinotecan (VI) for intermediate-risk rhabdomyosarcoma (IRRMS): A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
    Meeting Abstract

    Hawkins, D. S.; Anderson, J. R.; Mascarenhas, L.; McCowage, G. B.; Rodeberg, D. A.; Wolden, S. L.; Parham, D.; Million, L.; Donaldson, S. S.; Hayes-Jordan, A. A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save